The role of CXCL16 and its processing metalloproteinases ADAM10 and ADAM17 in the proliferation and migration of human mesangial cells

被引:43
|
作者
Schramme, Anja [1 ]
Abdel-Bakky, Mohamed Sadek [1 ]
Kaempfer-Kolb, Nicole [1 ]
Pfeilschifter, Josef [1 ]
Gutwein, Paul [1 ]
机构
[1] Goethe Univ Frankfurt, Pharmazentrum Frankfurt ZAFES, D-60590 Frankfurt, Germany
关键词
ADAM10; ADAM17; CXCL16; human mesangial cells; inflammation; migration; proliferation;
D O I
10.1016/j.bbrc.2008.03.088
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, we analyzed the regulation and functional role of CXCL16 in human mesangial cells (hMCs). We can show, that CXCL16 is constitutively expressed in hMCs and is further up-regulated by cytokine mix (IFN gamma, TNF alpha, and IL1 beta). The constitutive release of CXCL16 from hMCs was rapidly induced by the stimulation with cytokines. We identified ADAM10 and ADAM17 as being responsible for the cytokine-induced shedding of CXCL16. Notably, targeting ADAM 10 and ADAM17 in hMCs decreased the chemotaxis of T-Jurkat cells, whereas the inhibition of CXCL16 had no significant influence. This suggests that both proteases are important players in the recruitment of immune cells into the glomerulus, but other substrates than CXCL16 are involved in this process. Finally, we could show that the inhibition of CXCL16, ADAM10, and ADAM17 led to a strong reduction of cell proliferation and migration of hMCs. This finding could be important to develop novel diagnostic and therapeutic strategies to treat mesangial proliferative kidney diseases. (C) 2008 Elsevier Inc. All rights reserved.
引用
下载
收藏
页码:311 / 316
页数:6
相关论文
共 50 条
  • [1] ADAM10 is involved in IFN-γ induced CXCL16 cleavage in human mesangial cells
    Schramme, A.
    Schmehl, S.
    Hauser, I.
    Schaefer, L.
    Groene, H. -J.
    Pfeiischifter, J.
    Gutwein, P.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 68 - 68
  • [2] Evaluation of Proteoforms of the Transmembrane Chemokines CXCL16 and CX3CL1, Their Receptors, and Their Processing Metalloproteinases ADAM10 and ADAM17 in Proliferative Diabetic Retinopathy
    Abu El-Asrar, Ahmed M.
    Nawaz, Mohd Imtiaz
    Ahmad, Ajmal
    De Zutter, Alexandra
    Siddiquei, Mohammad Mairaj
    Blanter, Marfa
    Allegaert, Eef
    Gikandi, Priscilla W.
    De Hertogh, Gert
    Van Damme, Jo
    Opdenakker, Ghislain
    Struyf, Sofie
    FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [3] Metalloproteinases ADAM10 and ADAM17 Mediate Migration and Differentiation in Glioblastoma Sphere-Forming Cells
    Elodie J. Siney
    Alexander Holden
    Elizabeth Casselden
    Harry Bulstrode
    Gareth J. Thomas
    Sandrine Willaime-Morawek
    Molecular Neurobiology, 2017, 54 : 3893 - 3905
  • [4] Metalloproteinases ADAM10 and ADAM17 Mediate Migration and Differentiation in Glioblastoma Sphere-Forming Cells
    Siney, Elodie J.
    Holden, Alexander
    Casselden, Elizabeth
    Bulstrode, Harry
    Thomas, Gareth J.
    Willaime-Morawek, Sandrine
    MOLECULAR NEUROBIOLOGY, 2017, 54 (05) : 3893 - 3905
  • [5] Role of CXCL16 and ADAM10 in ovarian cancer pathogenesis
    Mir, Hina
    Kapur, Neeraj
    Lillard, James W.
    Singh, Shailesh
    CANCER RESEARCH, 2018, 78 (13)
  • [6] Downregulation of the metalloproteinases ADAM10 or ADAM17 promotes osteoclast differentiation
    Babendreyer, Aaron
    Kieselhorst, Julia
    Rinkens, Cindy
    Lyashenko, Anastasia M.
    Duesterhoeft, Stefan
    Jahr, Holger
    Craveiro, Rogerio B.
    Wolf, Michael
    Ludwig, Andreas
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [7] Characterization of CXCL16 and ADAM10 in the normal and transplanted kidney
    Schramme, Anja
    Abdel-Bakky, Mohamed Sadek
    Gutwein, Paul
    Obermueller, Nicholas
    Baer, Patrick C.
    Hauser, Ingeborg A.
    Ludwig, Andreas
    Gauer, Stefan
    Schaefer, Liliana
    Sobkowiak, Ewelina
    Altevogt, Peter
    Koziolek, Michael
    Kiss, Eva
    Groene, Hermann-Josef
    Tikkanen, Ritva
    Goren, Itamar
    Radeke, Heinfried
    Pfeilschifter, Josef
    KIDNEY INTERNATIONAL, 2008, 74 (03) : 328 - 338
  • [8] Assessment of ADAM17 and ADAM10 proteins with CXCL10 and thyroid autoimmunity in vitiligo pathogenesis
    Kilic, Sevilay
    Sehitoglu, Hilal
    Gul, Ceren
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2022, 39 (02): : 397 - 400
  • [9] Analysis of platelet function and GPVI regulation in mice lacking the metalloproteinases ADAM10 and ADAM17
    Bender, M.
    Hofmann, S.
    Stegner, D.
    Morowski, M.
    Kraft, P.
    Stoll, G.
    Chalaris, A.
    Braun, A.
    Scheller, J.
    Rose-John, S.
    Nieswandt, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 779 - 779
  • [10] The disintegrin-metalloproteinases ADAM10 and ADAM17 are upregulated in cutaneous squamous cell carcinomas
    Oh, S. -T.
    Stark, A.
    Reichrath, J.
    DERMATO-ENDOCRINOLOGY, 2016, 8 (01)